1
1
1
0.33
0
1
1
0.33
1-3
0
0.33
1
0.33-3
0-1
1-3
0.33-3
1-3
0.33-3
1-3
0.33-3
1-3
Description.
The doctoral program in Biostatistics trains future leaders, highly qualified as independent investigators and teachers, and who are well-trained practitioners of biostatistics. The program includes coursework in biostatistics, statistics, and one or more public health or biomedical fields. In addition, successful candidates are required to pass PhD applied and theory exams and write a dissertation that reports the results of new biostatistical research undertaken by the candidate.
Clinical medicine, epidemiologic studies, biological laboratory and field research, genetics, environmental health, health services, ecology, fisheries and wildlife biology, agriculture, and forestry.
Applicants usually have a degree in mathematics, statistics, or a biological field. All applicants should have the equivalent of 30 or more quarter credits in mathematics and statistics, including linear algebra, probability theory, and approximately 2 years of calculus.
Concurrent Option: PhD/MD
Application Deadline: Dec 1 - Autumn Quarter Entry
Upon satisfactory completion of the PhD in Biostatistics, graduates will be able to:
Learning objectives for the PhD program in Biostatistics in the Generic Pathway: Upon satisfactory completion of the PhD program in Biostatistics in the Generic Pathway, graduates will be able to:
Leverage your skills in statistics, computer science & software engineering and begin your career in the booming field of health data science
The Master of Science (SM) in Health Data Science is designed to provide rigorous quantitative training and essential statistical and computing skills needed to manage and analyze health science data to address important questions in public health and biomedical sciences.
The 16-month program blends strong statistical and computational training to solve emerging problems in public health and the biomedical sciences. This training will enable students to manage and analyze massive, noisy data sets and learn how to interpret their findings. The program will provide training in three principal pillars of health data science: statistics, computing, and health sciences.
Students in the program will learn to:
The SM in Health Data Science is designed to be a terminal professional degree, giving students essential skills for the job market. At the same time, it provides a strong foundation for students interested in obtaining a PhD in biostatistics or other quantitative or computational science with an emphasis in data science and its applications in health science.
Many issues in the health, medical and biological sciences are addressed by collecting and exploring relevant data. The development and application of techniques to better understand such data is a fundamental concern of our program.
This program offers training in the theory of statistics and biostatistics, computer implementation of analytic methods and opportunities to use this knowledge in areas of biological/medical research. The resources of Berkeley Public Health and the UC Berkeley Department of Statistics, together with those of other university departments, offer a broad set of opportunities to satisfy the needs of individual students. Furthermore, the involvement of UCSF faculty from the Department of Biostatistics and Epidemiology also enriches instructional and research activities.
A PhD degree in Biostatistics requires a program of courses selected from biostatistics, statistics, and at least one other subject area (such as environmental health, epidemiology, or genomics), an oral qualifying examination, and a dissertation. Courses cover traditional topics as well as recent advances in biostatistics and statistics. Those completing the PhD will have acquired a deep knowledge and understanding of the MA subject areas. Since graduates with doctorates often assume academic research and teaching careers, a high degree of mastery in research design, theory, methodology, and execution is expected, as well as the ability to communicate and present concepts in a clear, understandable manner.
The PhD degree program requires 4–6 semesters of coursework, the completion of the qualifying examination and dissertation (in total, a minimum of four semesters of registration is required). Biostatistics PhD students are required to take the following classes:
A Master’s degree in Biostatistics or a related field is recommended but not required for admission to the PhD program. Strongly recommended prerequisite courses are calculus, linear algebra, and statistics. Applicants admitted without a Master’s degree may be required to go through the Biostatistics MA curriculum; students can concurrently earn that degree with no additional cost or time to degree. Normative time to degree is 5 years.
Students entering with a relevant master’s degree in biostatistics or statistics must have a faculty advisor who is a member of the Biostatistics Graduate Group committing funding and mentorship support.
GRE General Test scores are required for admission to the Biostatistics PhD program however applicants are exempted from the requirement if they meet all of the following criteria:
Berkeley Public Health also exempts applicants who already hold a doctoral level degree from the GRE requirement.You can find more information on the application instructions page . There is a program page in the Berkeley Graduate Application where you can indicate you meet the criteria for GRE exemption. Applicants who are exempted from the GRE are not at a disadvantage in the application review process.
Many doctoral graduates accept faculty positions in schools of public health, medicine, and statistics and/or math departments at colleges and universities, both in the United States and abroad. Some graduates take research positions, including with pharmaceutical companies, hospital research units, non-profits, and within the tech sector.
Prospective students who are US citizens or permanent residents can find more information about applying for an application fee waiver for the Berkeley Graduate Application. Fees will be waived based on financial need or participation in selected programs described on the linked website. International applicants (non-US citizens or Permanent Residents) are not eligible for application fee waivers.
All PhD students are fully funded (including tuition and fees and a stipend or salary) with the exception of Non-Resident Supplemental Tuition (NRST) for the second year, if applicable. NRST is typically waived after the first year of study for PhD students when they advance to candidacy. Information on applying to GSI positions for biostatistics students can be found in the Biostatistics Division student handbook .
Tuition and fees change each academic year. To view the current tuition and fees, see the fee schedule on the Office of the Registrar website (in the Graduate: Academic section).
Please contact [email protected] if you have any questions about funding opportunities for the biostatistics programs.
The Division of Biostatistics is committed to challenging systemic inequities in the areas of health, medical, and biological sciences, and to advancing the goals of diversity, equity, and inclusivity in Biostatistics and related fields.
Diversity, Equity and Inclusion in Biostatistics
Emeritus faculty, faculty associated in biostatistics graduate group.
Coronavirus (COVID-19): Latest Updates | Visitation Policies Visitation Policies Visitation Policies Visitation Policies Visitation Policies | COVID-19 Testing | Vaccine Information Vaccine Information Vaccine Information
The application for Fall 2025 entry will open Summer 2024
The Department of Biostatistics and Computational Biology at the University of Rochester conducts teaching and research in statistical theory and methodology oriented toward the health sciences. Our unique graduate program is located within a School of Medicine environment and provides many opportunities for stimulating interaction with applied research.
The department interprets the term "statistics" very broadly, with specialization available in probability, statistical theory and analysis, biostatistics, and interdisciplinary areas of application. Department faculty participate fully in graduate teaching and individual attention is given to each student through intensive advising, extensive small seminars, and research collaboration. Students have opportunities for supervised teaching and statistical consulting experience. Prior to completing their degrees, most Ph.D. students have several publications underway based on research done in collaboration with faculty members in biostatistics/statistics and in various medical departments.
If you are looking for the Undergraduate Program in Statistics, please visit the School of Arts and Sciences .
Doctoral Students
Program Faculty
Year average time for Ph.D. completion
Job placement for Ph.D. graduates over the past 10 years
Program highlights.
From our highly skilled mentoring faculty to the Bioinformatics and Computational Biology Track, see what sets our program apart
Details of class schedules and full course descriptions can be found on our curriculum page
Our students most commonly reference the personal relationships and valuable mentoring they receive as one of the top reasons why they would recommend URMC
The Ph.D. in Statistics program offers students a thorough grounding in statistical theory, which provides the necessary foundation for the successful conduct of research in statistical methodology.
The Ph.D. in Statistics with Concentration in Bioinformatics and Computational Biology is designed to educate the next generation of biostatisticians with the knowledge required to address critical scientific and public health questions.
The M.A. in Statistics program is designed for students seeking preparation for a Ph.D. program or work as a Master’s-level statistician.
The M.S. in Biostatistics program is primarily intended for students who wish to follow careers in health-related professions such as those in the pharmaceutical industry and biomedical or clinical research organizations.
“I chose UR because I am excited by the opportunities available to students both during the program and after completing the program. Graduates from UR have gone on to do wildly different things in academia and industry. It is exciting to have every opportunity available to you, and UR certainly offers that in an environment that supports you in whatever path you choose to take.” “My favorite things about the program are the people I get to be surrounded by. My classmates are all brilliant and kind people that are a joy to learn alongside. The faculty have a wide range of research interests, which gives students the opportunity to truly carve out the career they want and are devoted to helping students do so.”
Connect with us on social media.
Tufts MD-PhD Program has a long-standing tradition of providing excellent and highly integrated training. The information below gives a snap-shot of our program.
KU's Ph.D. in Biostatistics program is nationally regarded for producing highly skilled biostatisticians prepared to collaborate or lead in a variety of fields.
The Ph.D. in Biostatistics at KU Medical Center is a 63-credit-hour program, recognized for the quality, ability and training of its graduating students. This fully accredited program includes collaborative research experience, annual evaluations, graduate examinations and the successful completion of a doctoral dissertation. Dissertation research culminates in a final dissertation examination which consists of an oral presentation by the candidate and an examination by the faculty.
The goal of the Ph.D. program is to produce biostatisticians who can develop biostatistical methodologies that can be utilized to solve problems in public health and the biomedical sciences. In addition, graduates will be prepared to apply biostatistical and epidemiology methodology for the design and analysis of public health and biomedical research investigations. Finally, graduates will be well-suited to function as collaborators or team leaders on research projects in the biomedical and public health sciences.
Download the Guide (PDF)
Upon completion of KU's Ph.D. in Biostatistics program, graduates will have the characteristics outlined for master's degree graduates and will possess the following additional skills:
University of Kansas Medical Center Department of Biostatistics & Data Science 3901 Rainbow Boulevard Mailstop 1026 Kansas City, KS 66160
We use cookies to analyze our traffic & provide social media features. Visit the KU Medical Center Privacy Statement for more information. By closing this window & browsing this site, you agree to our use of cookies.
Coronavirus (COVID-19): Latest Updates | Visitation Policies Visitation Policies Visitation Policies Visitation Policies Visitation Policies | COVID-19 Testing | Vaccine Information Vaccine Information Vaccine Information
Student opportunities, scientific conferences and meetings.
The Department of Biostatistics and Computational Biology recognizes the role of participation in meetings and conferences in the professional development of our doctoral students and strongly encourages such participation. Each student may apply for a maximum of $1,500 in support of travel expenses from central departmental funds over the course of their doctoral studies. Funds obtained from other sources, including awards provided directly by conference organizers, will be considered supplemental. Students are also encouraged to apply for travel awards in the School of Medicine and Dentistry.
PhD students may complete external internships during the summer. Students are encouraged to review the free professional development resources available through the school’s myHub before applying for internships. Career services offered include one-on-one counseling on interviewing skills, networking strategies, and developing strong CVs, resumes, and cover letters. International students studying on the F-1 visa will need to contact the University's International Services Office (ISO) for Curricular Practical Training (CPT) instructions.
The Department of Biostatistics and Computational Biology offers a Statistical Consulting Service with services ranging from purely advisory assistance to complete mathematical/statistical analysis and data management support for projects. Faculty members are available to serve as research collaborators and statistical consultants, with support from research associates and graduate research assistants. Doctoral students in their third year or higher will assist with consulting requests on a rotating schedule by attending consulting meetings with the faculty on-call and completing work requested by faculty for the research project.
The department has a colloquium series in which both senior and junior faculty from around the country travel to Rochester to give a seminar and meet with faculty and students. The department also hosts an annual lecture by a distinguished statistician in honor of Dr. Charles L. Odoroff, the founding Director of the Division of Biostatistics (now the Department of Biostatistics and Computational Biology) at the University of Rochester, and another annual lecture in honor of Dr. Andrei Yakovlev, who as Chair led a substantial expansion of the department, particularly in the areas of bioinformatics and computational biology.
All department members are invited to attend meetings on a variety of topics related to diversity, equity, and inclusion . The meetings are intended to raise awareness, provide a forum to discuss issues related to these topics, and provide an opportunity to learn from other people's stories and perspectives. Most meetings are open only to department members, and generally consist of watching a short video followed by small group discussions and concluding with a short discussion with the whole group. Topics have included microaggression and implicit bias. Some meetings are replaced by seminars given by outside speakers and are open to a wider audience. Topics of outside seminars have included hidden curriculum and pipeline programs for undergraduates to support diversity.
The Annual Statistics PhD Student Workshop includes presentations by all PhD students in the department who have passed the Advanced Examination but have not yet passed their Proposal (Qualifying) Examination. The primary purpose of the Workshop is to allow students to obtain feedback on their research ideas from the entire program faculty, whose perspectives may be somewhat different from that of the primary research advisor and potentially quite valuable. The Workshop also provides additional experience for each student in preparing and delivering a presentation on a topic of their particular interest.
Students who are considering a career in academia are invited to attend Future Faculty Workshops sponsored by the offices of the Provost and Faculty Development and Diversity. These workshops offer information and hands-on experience with aspects of faculty life not traditionally part of graduate curriculums. The series aims to prepare the next generation of faculty and to give University of Rochester graduates a competitive edge in the academic marketplace.
The school offers several optional interdepartmental (IND) courses related to scientific communication and leadership, including:
The Graduate Student Society (GSS) maintains a list of current student-run and University of Rochester organizations open to School of Medicine and Dentistry graduate student membership. The 2023-2024 GSS department representative is 4 th year PhD student Luke McHan.
The Rochester Data Science Society (RDSS) serves all students at the University who are interested in data science, statistics, computer science, engineering, health analytics, economics, and other related fields. The society was established in 2017 by Shiyang Ma (MA '15, PhD '19), along with students from the Health Services Research, Epidemiology, and Computer Science graduate programs.
B-1.1 | Total Enrollment by U.S. Medical School and Gender, 2014-2015 through 2018-2019 | ||
B-1.2 | Total Enrollment by U.S. Medical School and Gender, 2019-2020 through 2023-2024 | ||
B-2.1 | Total Graduates by U.S. Medical School, Gender, and Year, 2013-2014 through 2017-2018 | ||
B-2.2 | Total Graduates by U.S. Medical School, Gender, and Year, 2018- 2019 through 2022-2023 |
B-3 | Total U.S. Medical School Enrollment by Race/Ethnicity and Gender, 2019-2020 through 2023-2024 | ||
B-4 | Total U.S. Medical School Graduates by Race/Ethnicity and Gender, 2019-2020 through 2022-2023 | ||
B-5.1 | Total Enrollment by U.S. Medical School and Race/Ethnicity (Alone), 2023-2024 | ||
B-5.2 | Total Enrollment by U.S. Medical School and Race/Ethnicity (Alone or In Combination), 2023-2024 | ||
B-6.1 | Total Graduates by U.S. Medical School and Race/Ethnicity (Alone), 2022-2023 | ||
B-6.2 | Total Graduates by U.S. Medical School and Race/Ethnicity (Alone or In Combination), 2022-2023 | ||
B-14 | Enrollment and Graduates of U.S. MD-Granting Medical Schools by Race/Ethnicity (Alone) and Gender, 2020-2021 through 2023-2024 |
B-7 | MD-PhD Applicants to U.S. Medical Schools by Race/Ethnicity and State of Legal Residence, 2023-2024 | ||
B-8 | U.S. Medical School MD-PhD Applications and Matriculants by School, In-State Status, and Gender, 2023-2024 | ||
B-9 | MD-PhD Matriculants to U.S. Medical Schools by Race/Ethnicity and State of Legal Residence, 2023-2024 | ||
B-10 | MCAT Scores and GPAs for MD-PhD Applicants and Matriculants to U.S. Medical Schools, 2019-2020 through 2023-2024 | ||
B-11.1 | Total MD-PhD Enrollment by U.S. Medical School and Gender, 2014-2015 through 2018-2019 | ||
B-11.2 | Total MD-PhD Enrollment by U.S. Medical School and Gender, 2019-2020 through 2023-2024 | ||
B-12 | First-Year, Research LOA, and Total MD-PhD Enrollment by U.S. Medical School, 2023-2024 | ||
B-13 | Race/Ethnicity Responses (Alone and In Combination) of MD-PhD Graduates of U.S. Medical Schools, 2019-2020 through 2023-2024 | ||
B-15 | Total U.S. MD-Granting Medical School Enrollment by Race/Ethnicity (Alone), Gender, and Degree Program, 2023-2024 |
Chart 4 | Applicants, Matriculants, and Enrollment to U.S. Medical Schools, 1980-1981 through 2023-2024 | ||
Chart 5 | Graduates to U.S. Medical Schools by Gender, 1980-1981 through 2022-2023 | ||
Table 1 | Applicants, Matriculants, Enrollment, and Graduates to U.S. Medical Schools, 2014-2015 through 2023-2024 | ||
Table 2 | MD Graduates who Entered Residency Training at Programs Currently Affiliated or Not Affiliated with their Medical Schools of Graduation, 2015-2016 through 2021-2022 | ||
Table 3 | MD-PhD Graduates who Entered Residency Training at Programs Currently Affiliated or Not Affiliated with their Medical Schools of Graduation, 2015-2016 through 2021-2022 |
Graduation Rates and Attrition Rates of U.S. Medical Students (PDF) This AAMC Data Snapshot provides information on the graduation and attrition rates of U.S. Medical Students.
Awards: PhD, MScR
Study modes: Full-time, Part-time
Funding opportunities
Programme website: Population Health Sciences
Join us on the 26th June to learn more about studying at the University of Edinburgh.
Find out more and register
The Usher Institute supervises postgraduate research students in a wide range of population health disciplines, including epidemiology, genetic epidemiology, health promotion, health services research, medical statistics, molecular epidemiology and sociology and on a wide range of topics including allergic and respiratory disease, clinical trial and statistics methodology, eHealth, ethnicity and health, genetic epidemiology of complex diseases, global health, palliative care and cancer, society and health and families and relationships.
A principal aim is to foster interdisciplinary research involving quantitative and qualitative approaches via effective collaboration with biomedical scientists, epidemiologists, social scientists and clinical researchers throughout the University and beyond.
Before submitting an online application, prospective students should contact an academic members of staff who may act as first supervisor in order to align their research proposal with one of the Institute's main areas of research. A list of contacts for PhD supervisors can be found at:
Students will be integrated within the existing student-led approach at the Usher Institute, where structures are already in place to ensure a high-quality student experience.
The Centre for Population Health Sciences, which forms a large part of the Usher Institute, has a thriving PhD community with well-developed management and administrative structures.
University Quality Assurance monitoring and reporting processes will be adhered to. All supervisors will satisfy University requirements in terms of training and mentoring.
Expectations on the students, including assessment guidelines, will be clearly communicated by multiple channels (e.g. at interview, during induction, in the Postgraduate Research Student and Supervisor Handbook, by supervisors, at annual review meetings and on relevant web pages). All students will have at least two supervisors who will also give pastoral care and career advice in addition to student services provision.
Students will attend appropriate training, including transferable skills, at appropriate courses (e.g. from the Institute of Academic Development) identified in consultation with the supervisors.
The Usher Institute brings together researchers active in population health science research, including public health and primary care.
Within the school the Usher academic staff play a large role in research project supervision.
There are also links with the Institute of Genetics and Cancer and the Queen's Medical Research Institute.
These entry requirements are for the 2024/25 academic year and requirements for future academic years may differ. Entry requirements for the 2025/26 academic year will be published on 1 Oct 2024.
MSc by Research: A UK 2:1 honours degree, or its international equivalent.
PhD: A UK 2:1 honours degree and a UK masters degree with a mark of at least 60%, or their international equivalents. We will also consider a UK 2:1 honours degree, or its international equivalent, and significant work experience in an area relevant to your research project.
Check whether your international qualifications meet our general entry requirements:
Regardless of your nationality or country of residence, you must demonstrate a level of English language competency at a level that will enable you to succeed in your studies.
We accept the following English language qualifications at the grades specified:
Your English language qualification must be no more than three and a half years old from the start date of the programme you are applying to study, unless you are using IELTS , TOEFL, Trinity ISE or PTE , in which case it must be no more than two years old.
We also accept an undergraduate or postgraduate degree that has been taught and assessed in English in a majority English speaking country, as defined by UK Visas and Immigration:
We also accept a degree that has been taught and assessed in English from a university on our list of approved universities in non-majority English speaking countries (non-MESC).
If you are not a national of a majority English speaking country, then your degree must be no more than five years old* at the beginning of your programme of study. (*Revised 05 March 2024 to extend degree validity to five years.)
Find out more about our language requirements:
Tuition fees.
Award | Title | Duration | Study mode | |
---|---|---|---|---|
PhD | Population Health Sciences | 3 Years | Full-time | |
PhD | Population Health Sciences | 6 Years | Part-time | |
MScR | Population Health Sciences | 1 Year | Full-time | |
MScR | Population Health Sciences | 2 Years | Part-time |
Featured funding.
If you live in the UK, you may be able to apply for a postgraduate loan from one of the UK's governments.
The type and amount of financial support you are eligible for will depend on:
Programmes studied on a part-time intermittent basis are not eligible.
Search for scholarships and funding opportunities:
Select your programme and preferred start date to begin your application.
Phd population health sciences - 6 years (part-time), msc by research population health sciences - 1 year (full-time), msc by research population health sciences - 2 years (part-time), application deadlines.
We encourage you to apply at least one month prior to entry so that we have enough time to process your application. If you are also applying for funding or will require a visa then we strongly recommend you apply as early as possible.
You must submit two references with your application.
Before making your application, it is advisable to make contact with a potential supervisor to discuss your research proposal. Further information on making a research degree application can be found on the College website:
You will be formally interviewed (in person, by video-conferencing or Skype).
Find out more about the general application process for postgraduate programmes:
About the university, research at cambridge.
Postgraduate Study
The MRC Biostatistics Unit is an internationally recognised research department of the University of Cambridge specialising in statistical modelling with application to medical, biological or public health sciences.
Our PhD students are registered with the University of Cambridge. Students belong to one of the University's Colleges and are trained at our Unit at the University Forvie Site on the Cambridge Biomedical Campus at Addenbrooke's Hospital.
We maintain strong links with the University of Cambridge Statistical Laboratory, Alan Turing Institute and other mathematical departments (who are based in the Centre for Mathematical Sciences on the West Cambridge site).
Those who wish to progress to a PhD after completing an MPhil will be required to satisfy their potential supervisor, Head of Department and the Faculty Degree Committee that they have the skills and ability to achieve the higher degree.
The Postgraduate Virtual Open Day usually takes place at the end of October. It’s a great opportunity to ask questions to admissions staff and academics, explore the Colleges virtually, and to find out more about courses, the application process and funding opportunities. Visit the Postgraduate Open Day page for more details.
See further the Postgraduate Admissions Events pages for other events relating to Postgraduate study, including study fairs, visits and international events.
3-4 years full-time, 4-7 years part-time, study mode : research, doctor of philosophy, mrc biostatistics unit, course - related enquiries, application - related enquiries, course on department website, dates and deadlines:, lent 2024 (closed).
Some courses can close early. See the Deadlines page for guidance on when to apply.
Michaelmas 2024 (closed), easter 2025, funding deadlines.
These deadlines apply to applications for courses starting in Michaelmas 2024, Lent 2025 and Easter 2025.
Privacy Policy
Information compliance
Equality and Diversity
Terms of Study
About our website
Privacy policy
© 2024 University of Cambridge
An official website of the United States government
The .gov means it’s official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Preview improvements coming to the PMC website in October 2024. Learn More or Try it out now .
Marie a. krousel-wood.
* Ochsner Clinic Foundation, New Orleans, Louisiana
† Department of Epidemiology, Tulane School of Public Health and Tropical Medicine, New Orleans, Louisiana
Paul muntner, introduction.
This two-part series will present basic statistical principles for the practicing physician to use in his or her review of the literature and to the physician engaged in clinical research. The purpose of this series is threefold: (1) to provide an overview of common epidemiological and statistical terms and concepts that can be useful to the practitioner and clinical researcher, (2) to review calculations for common epidemiological measures and statistical tests, and (3) to provide examples from the published literature of uses of statistics in medical care and research. This review is not intended to be a comprehensive presentation of epidemiology or statistics since there are already a number of excellent sources for this information 1–6), but rather as a quick reference for practical application of statistical principles and concepts in medical care and clinical research.
In this issue, Part I of the Series is presented and includes discussion of the study question, study goals, appropriate study design, and appropriate statistical tests.
Physicians can be overwhelmed when reviewing published and current studies to determine what is relevant to their clinical practice and/or clinical research. Some initial questions outlined below may guide the process for reviewing an article or setting up a clinical study.
Whether in clinical practice or in a clinical research “laboratory,” physicians often make observations that lead to questions about a particular exposure and a specific disease. For example, one might observe in clinical practice that several patients taking a certain antihypertensive therapy develop pulmonary symptoms within 2 weeks of taking the drug. The physician might question if the antihypertensive therapy is associated with these symptoms. A cardiologist may observe in a review of the medical literature that the initial costs of caring for patients with cardiovascular diseases have been reported to be greater if the patient is cared for by a specialist than if the patient is cared for by a non-specialist. Because the physician may believe that although initial costs are greater, the follow-up costs are less, he or she may question if there would be a difference by specialist versus non-specialist if all costs were assessed. Questions like these can lead to formal hypotheses that can then be tested with appropriate research study designs and analytic methods. Identifying the study question or hypothesis is a critical first step in planning a study or reviewing the medical literature. It is also important to understand up front what the related study goals are. Some questions that may facilitate the process of identifying the study goals follow:
Once the study question(s) and goals have been identified, it is important to select the appropriate study design. Although the key classification scheme utilizes descriptive and analytic terminology, other terminology is also in vogue in evaluating health services and will be briefly described at the end of this section.
Epidemiology has been defined as “the study of the distribution and determinants of disease frequency” in human populations (4) . The primary classification scheme of epidemiological studies distinguishes between descriptive and analytic studies. Descriptive epidemiology focuses on the distribution of disease by populations, by geographic locations, and by frequency over time. Analytic epidemiology is concerned with the determinants, or etiology, of disease and tests the hypotheses generated from descriptive studies. Table 1 lists the study design strategies for descriptive and analytic studies. Below is a brief description of the various design strategies. The strengths and limitations of these study designs are compared in Table 2 .
Table 1: Outline of Study Design Strategies for Descriptive and Analytic Studies.
Table 2: Strengths and Limitations of Descriptive and Analytic Study Designs*
Correlational studies, also called ecologic studies, employ measures that represent characteristics of entire populations to describe a given disease in relation to some variable of interest (e.g. medication use, age, healthcare utilization). A correlation coefficient (i.e. Pearson's “r”; Spearman's “T”; or Kendall's “K”) quantifies the extent to which there is a linear relationship between the exposure of interest or “predictor” and the disease or “outcome” being studied. The value of the coefficient ranges between positive 1 and negative 1. Positive 1 reflects a perfect correlation where as the predictor increases, the outcome (or risk of outcome) increases. Negative 1 reflects a perfect inverse correlation where as the predictor increases the outcome (or risk of outcome) decreases. An example of a correlation study would be that of St Leger and colleagues who studied the relationship between mean wine consumption and ischemic heart disease mortality (7) . Across 18 developed countries, a strong inverse relationship was present. Specifically, countries with higher wine consumption had lower rates of ischemic heart disease and countries with lower wine consumption had higher rates of ischemic heart disease. Although correlation studies provide an indication of a relationship between an exposure and an outcome, this study design does not tell us whether people who consume high quantities of wine are protected from heart disease. Thus, inferences from correlation studies are limited.
Case reports and case series are commonly published and describe the experience of a unique patient or series of patients with similar diagnoses. A key limitation of the case report and case series study design is the lack of a comparison group. Nonetheless, these study designs are often useful in the recognition of new diseases and formulation of hypotheses concerning possible risk factors. In a case series study reported by Kwon and colleagues (8) , 47 patients were examined who developed new or worsening heart failure during treatment with tumor necrosis factor (TNF) antagonist therapy for inflammatory bowel disease or rheumatoid arthritis. After TNF antagonist therapy, 38 patients (of which 50% had no identifiable risk factors) developed new-onset heart failure and 9 experienced heart failure exacerbation. From this descriptive study, the authors concluded that TNF antagonist might induce new-onset heart failure or exacerbate existing disease (8) .
Cross-sectional surveys are also known as prevalence surveys. In this type of study, both exposure and disease status are assessed at the same time among persons in a well-defined population. These types of studies have become more common recently with the development and validation of survey tools such as the Short Form 36 (SF 36) functional status questionnaire and the Kansas City Cardiomyopathy Questionnaire (KCCQ) functional status survey. Cross-sectional studies are especially useful for estimating the population burden of disease. The prevalence of many chronic diseases in the United States is calculated using the National Health and Nutrition Examination Survey, an interview and physical examination study including thousands of non-institutionalized citizens of the United States. For example, Ford and colleagues estimated that 47 million Americans have the metabolic syndrome using the Third National Health and Nutrition Examination Survey (9) . Of note, in special circumstances where one can easily deduce an exposure variable preceding the outcome or disease, cross sectional surveys can be used to test epidemiologic hypotheses and thus can be used as an analytic study. For example, Bazzano and colleagues used data collected from a cross-sectional study to conclude that cigarette smoking may raise levels of serum C-reactive protein (10) . A cross-sectional study is useful in this situation because it is unlikely that having high levels of C-reactive protein would cause one to smoke cigarettes.
Analytic studies can be observational or experimental. In observational studies, the researchers record participants' exposures (e.g., smoking status, cholesterol level) and outcomes (e.g., having a myocardial infarction). In contrast, an experimental study involves assigning one group of patients to one treatment and another group of patients to a different or no treatment. There are two fundamental types of observational studies: case control and cohort. A case control study is one in which participants are chosen based on whether they do (cases) or do not (controls) have the disease of interest. Ideally, cases should be representative of all persons developing the disease and controls representative of all persons without the disease. The cases and controls are then compared as to whether or not they have the exposure of interest. The difference in the prevalence of exposure between the disease/no disease groups can be tested. In these types of studies, the odds ratio is the appropriate statistical measure that reflects the differences in exposure between the groups.
The defining characteristic of a cohort study, also known as a follow-up study, is the observation of a group of participants over a period of time during which outcomes (e.g., disease or death) develop. Participants must be free from the disease of interest at the initiation of the study. Subsequently, eligible participants are followed over a period of time to assess the occurrence of the disease or outcome. These studies may be classified as non-concurrent/retrospective or concurrent/prospective.
Retrospective cohort studies refer to those in which all pertinent events (both exposure and disease) have already occurred at the time the study has begun. The study investigators rely on previously collected data on exposure and disease. An example of a non-concurrent/retrospective cohort study would be that of Vupputuri and colleagues (11) , who in 1999–2000 abstracted data on blood pressure and renal function from charts for all patients seen at the Veterans Administration Medical Center of New Orleans Hypertension Clinic from 1976 through 1999. They analyzed the data to see if blood pressure at each patient's first hypertension clinic encounter was associated with a subsequent deterioration in renal function.
In prospective studies, the disease/outcome has not yet occurred. The study investigator must follow participants into the future to assess any difference in the incidence of the disease/outcome between the types of exposure. The incidence of the disease/outcome is compared between the exposed and unexposed groups using a relative risk (RR) calculation. The advantages of retrospective cohort studies, relative to prospective, include reduced cost and time expenditures as all outcomes have already occurred. In contrast, the major disadvantage of the non-concurrent/retrospective studies is the reliance on available data that were collected for clinical purposes and, generally, not following a carefully designed protocol. There are two additional sub-classifications for cohort studies. First, cohort studies may include a random sample of the general population, e.g., Framingham and Atherosclerosis Risk in Communities (12–16) or a random sample of a high-risk population (17) . In these latter studies, a sample of all individuals or individuals with a specific demographic, geographic, or clinical characteristic is included. Second, cohort studies may begin by identifying a group of persons with an exposure and a comparison group without the exposure. This type of cohort study is usually performed in the situation of a rare exposure.
Experimental or intervention studies are commonly referred to as clinical trials. In these studies, participants are randomly assigned to an exposure (such as a drug, device, or procedure). “The primary advantage of this feature (ed: randomized controlled trials) is that if the treatments are allocated at random in a sample of sufficiently large size, intervention studies have the potential to provide a degree of assurance about the validity of a result that is simply not possible with any observational design option” (5) . Experimental studies are generally considered either therapeutic or preventive. Therapeutic trials target patients with a particular disease to determine the ability of a treatment to reduce symptoms, prevent recurrence or decrease risk of death from the disorder. Prevention trials involve the assessment of particular therapies on reducing the development of disease in participants without the disease at the time of enrollment. One such prevention trial is the Drugs and Evidence Based Medicine in the Elderly (DEBATE) Study, which has as its primary aim “ to assess the effect of multi-factorial prevention on composite major cardiovascular events in elderly patients with atherosclerotic diseases” (18) .
Some other classification schemes in use today are based on the use of epidemiology to evaluate health services. Epidemiological and statistical principles and methodologies are used to assess health care outcomes and services and provide the foundation for evidence-based medicine. There are different ways to classify studies that evaluate health care services. One such scheme distinguishes between process and outcomes studies. Process studies assess whether what is done in the medical care encounters constitutes quality care (e.g. number and type of laboratory tests ordered, number and type of medications prescribed, frequency of blood pressure measurement). An example of a process study would be one that evaluated the percentage of patients with chronic heart failure in a given population who have filled prescriptions for angiotensin converting enzyme inhibitors (ACE – Inhibitors). A criticism of process studies is that although they document whether or not appropriate processes were done, they don't indicate if the patient actually benefited or had a positive outcome as a result of the medical processes.
Outcomes studies assess the actual effect on the patient (e.g. morbidity, mortality, functional ability, satisfaction, return to work or school) over time, as a result of their encounter(s) with health care processes and systems. An example of this type of study would be one that assessed the percentage of patients with a myocardial infarction (MI) who were placed on a beta blocker medication and subsequently had another MI. For some diseases, there may be a significant time lag between the process event and the outcome of interest. This often results in some patients being lost to follow-up, which may lead to erroneous conclusions unless methods that “censor” or otherwise adjust for missing time-dependent covariates are used.
In reviewing the medical literature, one often encounters other terms that deal with the evaluation of medical services: efficacy, effectiveness, or efficiency. Efficacy evaluates how well a test, medication, program or procedure works in an experimental or “ideal” situation. Efficacy is determined with randomized controlled clinical trials where the eligible study participants are randomly assigned to a treatment or non-treatment, or treatment 1 versus treatment 2, group. Effectiveness assesses how well a test, medication, program or procedure works under usual circumstances. In other words, effectiveness determines to what extent a specific healthcare intervention does what it is intended to do when applied to the general population. For example, although certain anti-retroviral therapies work well using direct observed therapy in the controlled setting of a clinical trial (i.e., they are efficacious), once applied to a free-living population, the drug dosing regimen may be too difficult for patients to follow in order to be effective. Finally, efficiency evaluates the costs and benefits of a medical intervention.
Once the appropriate design is determined for a particular study question, it is important to consider the appropriate statistical tests that must be (or have been) performed on the data collected. This is relevant whether one is reviewing a scientific article or planning a clinical study. To begin, we will look at terms and calculations that are used primarily to describe measures of central tendency and dispersion. These measures are important in understanding key aspects of any given dataset.
There are three commonly referred to measures of central location: mean, median, and mode. The arithmetic mean or average is calculated by summing the values of the observations in the sample and then dividing the sum by the number of observations in the sample. This measure is frequently reported for continuous variables: age, blood pressure, pulse, body mass index (BMI), to name a few. The median is the value of the central observation after all of the observations have been ordered from least to greatest. It is most useful for ordinal or non-normally distributed data. For data sets with an odd number of observations, we would determine the central observation with the following formula:
For datasets with an even number of observations, we would select the case that was the average of the following observations' values:
The mode is the most commonly occurring value among all the observations in the dataset. There can be more than one mode. The mode is most useful in nominal or categorical data. Typically no more than two (bimodal) are described for any given dataset.
Example 1: A patient records his systolic blood pressure every day for one week. The values he records are as follows: Day 1: 98 mmHg, Day 2: 140 mmHg, Day 3: 130 mmHg, Day 4: 120 mmHg, Day 5: 130 mmHg, Day 6: 102 mmHg, Day 7: 160 mmHg.
The arithmetic mean or average for these 7 observations is calculated as follows:
Table 3: Advantaged and Disadvantages of Measure of Central Tendency and Dispersion*
Measures of dispersion or variability provide information regarding the relative position of other data points in the sample. Such measures include the following: range, inter-quartile range, standard deviation, standard error of the mean (SEM), and the coefficient of variation.
Range is a simple descriptive measure of variability. It is calculated by subtracting the lowest observed value from the highest. Using the blood pressure data in example 1, the range of blood pressure would be 160 mmHg minus 98 mmHg or 62 mmHg. Often given with the median (i.e., for non-normally distributed data) is the interquartile range, which reflects the values for the observations at the 25th and 75th percentiles of a distribution.
The most commonly used measures of dispersion include variance and its related function, standard deviation, both of which provide a summary of variability around the mean. Variance is calculated as the sum of the squared deviations divided by the total number of observations minus one:
The standard deviation is the square root of the variance. Table 4 presents calculations of variance and standard deviation for the systolic blood pressures given in example 1.
Table 4: Example of a Standard Deviation Calculation
The coefficient of variation (CV) is a measure that expresses the SD as a proportion of the mean:
This measure is useful if the clinician wants to compare 2 distributions that have means of very different magnitudes. From the data provided in example 1, the coefficient of variation would be calculated as follows:
The standard error of the mean (SEM) measures the dispersion of the mean of a sample as an estimate of the true value of the population mean from which the sample was drawn. It is related to, but different from, the standard deviation. The formula is as follows:
Using the data from example 1, the SEM would be:
SEM can be used to describe an interval within which the true sample population mean lies, with a given level of certainty. Which measure of dispersion to use is dependent on the study purpose. Table 3 provides some information which may facilitate the selection of the appropriate measure or measures.
Once central tendency and dispersion are measured, it follows that a comparison between various groups (e.g., level of systolic blood pressure among persons taking ACE-Inhibitors versus beta-blockers) is desired. If working with continuous variables that are normally distributed, the comparison is between means. The first step is to simply look at the means and see which is larger (or smaller) and how much difference lies between the two. This step is the basis of deductive inference. In comparing the means, and, preferably before calculating any p-values, the clinician or investigator must answer the question: is the observed difference clinically important? If the magnitude of the observed difference is not clinically important, then the statistical significance becomes irrelevant in most cases. If the observed difference is clinically important, even without statistical significance, the finding may be important and should be pursued (perhaps with a larger and better powered study; Table 5 ).
Clinical Versus Statistical Significance and Possible Conclusions
Once a deductive inference is made on the magnitude of the observed differences, statistical inference follows to validate or invalidate the conclusion from the deductive inference. To illustrate: if two people each threw one dart at a dartboard, would one conclude that whoever landed closer to the center was the more skilled dart thrower? No. Such a conclusion would not be reasonable even after one game or one match as the result may be due to chance. Concluding who is a better player would have to be based on many games, against many players, and over a period of time. There are many reasons for inconsistencies (good day, bad day, etc.), but they all boil down to variance. For a player to be classified as a “good player,” he/she has to be consistently good over time.
Because in clinical research we rely on a sample of the patient population, variance is a key consideration in the evaluation of observed differences. The observed difference between exposed and unexposed groups can be large, but one must consider how it stands next to the variation in the data. Since these parameters are highly quantifiable, the probability that the means are different (or similar) can be calculated. This process takes place in a statistical method called analysis of variance (ANOVA). The details of this process are beyond the scope of this chapter; nevertheless, ANOVA is a fundamental statistical methodology and is found in many texts and is performed by many statistical software packages. In essence, the ANOVA answers the question: are differences between the study groups' mean values substantial relative to the overall variance (all groups together)? It is important to note that even though ANOVA reveals statistically significant differences, the ANOVA does not indicate between which groups the difference exists. Therefore, further analysis with multiple comparison tests must be performed to determine which means are significantly different. Portney and Watkins (19) provide a good overview of these procedures.
In the special case where one and only one comparison can be made, the t-test can be done. It was developed to be a shortcut comparison of only two means between groups with small sample sizes (less than 30). If used for more than one comparison or when more than one comparison is possible, the t-tests do not protect against Type 1 error at the assumed level of tolerance for Type 1 error (usually α = 0.05).
Armed with a basic understanding of algebra and user-friendly statistical software, most clinicians and clinical researchers can follow the cookbook method of statistical inference. Problems quickly arise because the vast majority of medical research is not designed as simply as the examples given in basic statistics textbooks nor analyzed as simply as the shortcut methods often programmed beneath the layers of menus in easy-to-use software. Violations of assumptions that are necessary for a classic statistical method to be valid are more the rule than the exception. However, avoiding the misinterpretation of statistical conclusions does not require advanced mastery of the mathematics of probability at the level of calculus. An effort to understand, at least qualitatively, how to measure the degree of belief that an event will occur will go a long way in allowing non-mathematicians to make confident conclusions with valid methods.
Two practical concepts should be understood up front: first, understanding that every probability, or rate, has a quantifiable uncertainty that is usually expressed as a range or confidence interval. Second, that comparing different rates observed between two populations, or groups, must be done relative to the error terms. This is the essence of statistical inference.
The final rate of an event that is measured, as the size of the sample being measured grows to include the entire population, is the probability that any individual in the population will experience the event. For example, one analyzes a database of heart transplant patients who received hearts from donors over the age of 35 to determine the rate of cardiac death within a 5-year post-transplant follow-up period (20) . If the first patient in the sample did not survive the study period, the sample of this one patient gives an estimated cardiac death rate of 100%. No one would accept an estimate from a sample of one. However, as the sample size increases, the event rate will migrate towards truth. If the next patient in the database is a survivor, the cardiac death rate falls to 50%. Once the entire population represented in the database is included in the sample (n=26), it is observed that 7 experienced cardiac death for a final cardiac death rate of 27%. When written as a probability, one can say that the probability is 0.27 that any single participant randomly sampled from this database will be recorded as having a cardiac death within 5 years of receiving a heart transplant. It may be more relevant to use the data to predict that the next patient seen in clinic and added to the database will have a probability of 0.27 of experiencing cardiac death within 5 years. The illustration just described is that of a binomial probability. That is, the outcome is one of two possible levels (binary): survival or death.
For this example, the SE is calculated by:
The Z score for a two sided 95% confidence interval (CI) is 1.96, so the range of the CI is calculated by lower 95% CI = 0.27 − 1.96 × 0.087 = 0.011 and upper 95% CI = 0.27 + 1.96 × 0.087 = 0.440, respectively. These yield the range (.011, .440). Thus, if this observation were repeated 100 times in similar populations of the same sample size, 95 of the sampled death rates would fall between .011 and .440.
In order to understand disease etiology and to provide appropriate and effective health care for persons with a given disease, it is essential to distinguish between persons in the population who do and do not have the disease of interest. Typically, we rely on screening and diagnostic tests that are available in medical facilities to provide us information regarding the disease status of our patients. However, it is important to assess the quality of these tests in order to make reasonable decisions regarding their interpretation and use in clinical decision-making (1) . In evaluating the quality of diagnostic and screening tests, it is important to consider the validity (i.e. sensitivity and specificity) as well as the predictive value (i.e. positive and negative predictive values) of the test.
Sensitivity is the probability (Pr) that a person will test positive (T+) given that they have the disease (D+). Specificity is the probability (Pr) that a person will test negative (T−) given that they do not have the disease (D−). These are conditional probabilities. The result in question is the accuracy of the test, and the condition is the true, yet unknown, presence or absence of the disease. Sensitivity and specificity are properties of the screening test, and, like physical properties, follow the test wherever it is used. They can be useful in determining the clinical utility of the test (as a screening tool vs. a diagnostic tool) as well as comparing new tests to existing tests. They are written mathematically as:
It is more common for sensitivity and specificity to be expressed from a 2×2 contingency table (Table 6) as follows:
Table 6: 2×2 Contigency Table – Test Characteristics
These parameters quantify the validity of a test when it is evaluated in a population that represents the spectrum of patients in whom it would be logical and clinically useful to use the test. The most obvious limitation of evaluating a screening test is identifying an optimal gold standard to determine the disease status. In the evaluation of new screening tests, existing tests are often used as the gold standard. Disagreement or poor sensitivity and specificity of the new test could mean that the new test does not work as well as, or that it is actually superior to, the existing test. A histological test from a biopsy is the least disputable gold standard. Nonetheless, the limitation with regards to the gold standard is unavoidable and must be recognized in the continuous evaluation of clinical screening and diagnostic testing.
In a study to evaluate bedside echocardiography by emergency physicians to detect pericardial effusion, 478 eligible patients were evaluated for the condition both by the emergency department physician and by the cardiologist (who had the clinical responsibility to make the diagnosis); the cardiologist's finding was used as the gold standard (21) .
An excerpt of the results is shown in Table 7 . From the data presented in the table, the following can be calculated:
Table 7: 2×2 Contingency Table for Pericardial Effusion Study
Since the sensitivity and specificity are like physical properties of the test, we can determine the portion of TP and TN regardless of the prevalence of the disease in the population studied. For example, if we had recruited 100 patients with pericardial effusion and 100 matching participants without pericardial effusion, the resulting table would yield the same rates of TP, TN, and identical values for sensitivity and specificity (Table 8) .
Table 8: 2×2 Contingency Table for Pericardial Effusion Example
Positive predictive value (PPV) is the probability (Pr) that the disease is truly present (D+) given that the test result is positive (T+). Negative predictive value (NPV) is the probability that the disease is truly absent (D−) given that the test result is negative (T−). Generally speaking, patients (and their physicians) are more concerned with these probabilities. These are also conditional probabilities. These parameters are written mathematically as:
PPV = Pr(D + |T + ), and NPV = Pr(D − |T − ). As with sensitivity and specificity, it may be more common to see the algebraic expressions:
The question is whether or not the individual patient's test result is true. Unlike sensitivity and specificity, PPV and NPV are dependent upon the prevalence of the disease in the population. The example below further illustrates this point.
Figure 1 shows PPV and NPV over the entire range of possible prevalence with sensitivity and specificity fixed at the values in the illustration. PPV and NPV are used to make clinical decisions concerning an individual patient based on the population from which the patient comes. As prevalence increases, PPV increases and NPV decreases. Thus, in populations where disease prevalence is high, there will be greater confidence that a positive test result is a true positive, and increased suspicion that a negative test result is a false negative. The reverse is true in populations where the disease prevalence is low (e.g. rare disease).
Figure 1: Effect of Prevalence on Positive and Negative Predictive Values
Diagnostic and screening tests, and their related sensitivities, specificities, PPVs and NPVs, facilitate the clinician's classification of a patient with regard to a specific disease status. The ultimate goal of the diagnostic process is to establish a diagnosis with sufficient confidence to justify treatment or to exclude a diagnosis with sufficient confidence to justify non-treatment (22) . In the process of determining a diagnosis (or not), the test results for a given disease should be kept within the context of the probability of disease prior to receiving results. Bayesian logic is the understanding of conditional probability which is expressed mathematically in Baye's Theorem. The theorem “indicates that the result of any diagnostic test alters the probability of disease in the individual patient because each successive test result reclassifies the population from which the individual comes” (22) .
Measures of association are summary statistics that estimate the risk of an outcome or disease for a given exposure between two groups. Two frequently reported measures are the odds ratio and the relative risk. The odds ratio (OR) is calculated from a case-control study where the participants were selected by their outcome and then studied to determine exposure. Because the participants are selected on outcome, the case-control study reveals the prevalence of exposure among cases and controls. In case-control studies we calculate odds ratios because it is often a good estimate of the relative risk. Odds are the probability of an event occurring divided by the probability of the event not occurring. The OR ratio compares the odds of being exposed given a participant is a case ( Table 9 : a / a+c / c / a+c = a/c) relative to the odds of control participants being exposed (b/b+d / d / b+d = b/d). Using algebra to re-arrange the formula, the OR can be calculated as (Table 9) :
Table 9: Cell Naming Scheme for Doing Calculations from a 2 × 2 Table
Table 10: Diagram of Observed Frequencies Extracted for Odds Ratio Example
The relative risk or risk ratio (RR) is calculated from a cohort study where exposed and non-exposed participants are followed over time and the incidence of disease is observed. Because the hallmark of a cohort study is following a population over time to identify incident cases of disease, the cohort is screened to assure that no participant enrolled in the study has already experienced the outcome or disease event. Then, the cohort is followed for a specific period of time, and the incidence of events for the exposed and unexposed groups is measured. The relative risk can also be used to analyze clinical trial data. The relative risk (RR) is calculated from the labeled 2×2 table (Table 9) using the formula:
Table 11: Observed Frequencies Extracted from Relative Risk Example*
Both the OR and RR have confidence intervals (CI) as a measure of uncertainty. The method is similar to the one used for the binomial probability distribution. If a 95% CI excludes the value one (1) , then the ratio is significant at the level of p<0.05. A test of independence, as a category of methods, tests the hypothesis that the proportion of an outcome is independent of the grouping category. The alternate hypothesis, the conclusion made when the p-value is significant (p<0.05), is that the disease or outcome is more common among the exposed or unexposed group.
Chi-square tests are used to determine the degree of belief that an observed frequency table could have occurred randomly by comparing it to an expected frequency table. The expected frequency table is derived based on the assumption that the row and column totals are true as observed and fixed. The most commonly used chi-square test is the Pearson's chi-square test. This is used to analyze a frequency table with two rows and two columns. When the table is not symmetrical or is of dimensions other than 2-by-2, the method is still valid, and when used is called the Cochran's chi-square test. At the very least, the largest observed difference is significant if the table is significant. If the overall table is significant, this global significance can allow stratified sub-analyses of the individual comparisons of interest. It can also be helpful to look at the contribution to the chi-square test statistic by each cell and conclude that the largest of these cells are where the observed frequencies most deviated from the expected frequencies.
Table 12: Components for Calculating a 95% Confidence Interval Around Measures of Association
Tests of proportional disagreement are for paired data, either repeated measures in the same participants or participants matched on demographic factors then given different exposures and followed to compare outcomes. The best known of the tests of proportional disagreement is the McNemar's chi-square test. The outcome of paired data falls into four observations (++, −–, +–, −+). McNemar's test focuses on the discordant cells (+–, −+) and tests the hypothesis that the disagreement is proportional between the two groups. If when the outcome disagrees, the disagreement is more frequently −+ than +–, then we know that more pairs are improving or having better outcomes. A relatively new application of tests for paired data is the Combined Quality Improvement Ratio (CQuIR), which uses the McNemar's chi-square test as the basis, but combines participants with repeated measures and case-control matched pairs into one large database of analyzable pairs. This process maximizes the statistical power available from the population ( 25 , 26 ). Additionally, the ratio of discordant pairs (−+/+−) shows whether or not the disagreement is more often toward improvement. Included in the tests of disproportion is the Kappa statistic of agreement. The Kappa statistic evaluates the concordant cells (++ and −−) to conclude whether or not the agreement has enough momentum to be reproducible.
Thus far, we have used examples for analyses from observational studies. Experimental studies or clinical trials are analyzed in much the same manner. In clinical trials, patients are followed until some outcome is observed in the planned study period; these are incidence studies. As incidence studies, the RR will be the measure of association tested for statistical significance. Additionally, many clinical trials lend themselves to straightforward analyses with chi-square tests, ANOVA, or other methods that result only in a p-value. Table 13 summarizes common methods used to analyze healthcare data.
Measures of Association and Statistical Tests Commonly Used to Analyze Healthcare Data
For one example, we review the results of a trial of the beta-blocker, bucindolol, used in patients with advanced chronic heart failure (CHF) (27) . While it is accepted that beta-blockers reduce morbidity and mortality in patients with mild to moderate CHF, these investigators enrolled 2708 patients designated as New York Heart Association (NYHA) class III or IV to test the efficacy of the beta-blocker in reducing morbidity and mortality in patients with high baseline severity. The primary outcome of interest was all-cause-mortality, which, being a relatively rare event, drove the sample size requirement to 2800 in order to statistically detect a clinically significant difference of 25%. Once enrolled, patients were randomly assigned to receive either placebo or the beta-blocker, and neither the patient nor the physician knew to which treatment the patient was assigned. This study was stopped after the seventh interim analysis due to the accruing evidence of the usefulness of beta-blockers for CHF patients from other studies. At the time the study was stopped, there was no difference in mortality between the two groups (33% in the placebo group vs. 30% in the beta-blocker group, p=0.16). After the follow-up data was completed, adjustments for varying follow-up time could be made. The adjusted difference in mortality rate was still not significant (p=0.13). However, a sub-analysis of the secondary endpoint of cardiac death did yield a significant hazard ratio (HR) of 0.86 with a 95% CI of 0.74 to 0.99. This HR being less than the value 1 means that the beta-blocker was protective against cardiac death in the follow-up period. The CI not including the value 1 leads to the conclusion that this HR is statistically significant at the level of p<0.05. This secondary analysis is consistent with the decision of the study group to stop the trial early.
This concludes Part I of the series. In the next issue of The Ochsner Journal , we will present Part II which includes discussion of the significance of the study results, relevance of the results in clinical practice, and study limitations.
Table 14: Classification of Random Error
Statistical Science
The Statistical Science research programme at UCL aims to develop research students who can eventually make original contributions to the subject. Students are initially registered for the MPhil degree. No sooner than one year, they are transferred to the PhD degree with retrospective effect if they show a capacity for original work. The typical length of the PhD programme is three years for full-time students and five years for part-time students; an MPhil might be achievable in less.
The admissions process for the MPhil/PhD in Statistical Science operates on a rolling basis, with no fixed deadline for applications. Candidates should apply at least two months in advance of their intended start date.
The MPhil/PhD is accessible to students with, or expecting to achieve, a minimum of an upper second-class UK Bachelor’s degree, or a UK Master’s degree in statistics, mathematics, computer science or a related quantitative discipline. Overseas qualifications of an equivalent standard are also acceptable.
In addition to the academic requirements above, all students whose first language is not English must be able to provide recent evidence that their spoken and written command of the English language is adequate. For the MPhil/PhD in Statistical Science, applicants much reach at least the UCL standard level. Further information on this requirement is available at the link below.
In applying for admission to the MPhil/PhD programme, candidates are expected to prepare an outline proposal of their work. This is crucial in identifying potential supervisors. Thus, candidates should peruse the research interests of staff before applying. A list of staff members currently accepting applications for PhD supervision is given below, including an indication of their current research interests and a link to their personal webpage.
It may be helpful to contact a potential supervisor before submitting a formal application. For more information on how to contact potential supervisors and write a research proposal please see UCL's guidance document . Applications on which no potential supervisor has been specified will still receive consideration, however, in such cases it would be especially important to demonstrate in your reasons for applying that your academic interests align with the Department's active research areas .
Researcher | Research Interest Keywords | |
---|---|---|
Medical statistics, formulation and validation of risk prediction models, methods to handle missing data, hierarchical models, clinical trials | ||
Bayesian statistical modelling for cost effectiveness analysis and decision-making problems in the health systems, hierarchical/multilevel models and causal inference using the decision-theoretic approach | ||
Medical statistics, randomised trials and large epidemiological studies, statistical issues in design and analysis of trials | ||
Statistical genomics and more generally statistics for cell biology (N.B. not population genetics), sparse multivariate models (frequentist or Bayesian), stochastic networks | ||
Sequential Monte-Carlo, Markov chain Monte-Carlo, Bayesian statistics, computational statistics, Monte-Carlo algorithms in high-dimensions, inverse problems, inference, applications and simulation for stochastic differential equations, fractional and white noise in econometrics, hidden Markov models, biostatistics | ||
Computational statistics, Monte Carlo methods, kernel methods, machine learning, statistical emulators, Gaussian processes | ||
Environmental applications, climate projections, uncertainty analysis, space-time modelling | ||
Probability theory applied to physics and biology, optimal transport theory, statistical mechanics | ||
Machine learning, Bayesian statistics | ||
Bayesian statistics, regression, time series, computational methods for Bayesian inference, high-dimensional and nonparametric statistics, bioinformatics, applications: economics, finance, ecology, the environment, and sport science | ||
Uncertainty quantification of computer models, functional data, time series, high-dimensional statistics, environmental statistics | ||
Jeremias Knoblauch | Machine learning, robustness, Bayesian inference, Generalised Bayesian methodology, variational methods, time series | |
Uncertainty quantification of computer models, functional data, time series, high-dimensional statistics, environmental statistics | ||
Medical statistics, missing data, multiple imputation, clinical trials, cluster-randomised trials, health economics | ||
Bayesian computation, Monte Carlo, Markov chains, encrypted statistics | ||
Computational stochastic optimisation, quantitative risk management, decision making under uncertainty | ||
Bayesian statistics, semi- and non-parametric modelling, mixture modelling, state-space models, health data science, heterogeneous data | ||
Penalized likelihood based inference, copula regression modelling, generalized additive modelling, endogeneity, non-random sample selection, observed and unobserved confounding, generalized regression, computational statistics, parametric and nonparametric survival modelling, simultaneous equation modelling, applications in various areas | ||
Extreme value modelling; statistical methods for the environmental sciences, e.g. off-shore engineering, climate science and hydrology | ||
Medical statistics, biostatistics, missing data, clustered data (e.g. multicentre studies, repeated measurement studies), risk prediction models, trial (not early phase drug trials) methodology | ||
Risk prediction modelling, analysis of clustered data, informative cluster size, missing data, penalised regression, methods for comparing institutional performance. | ||
Stochastic differential equations, Gaussian Markov random fields, Bayesian inverse problems | ||
Bayesian Statistics; Model Selection; Survival Models; Longitudinal Models; Biostatistics; Computational Statistics | ||
Graphical models, random network modelling, social networks, causal inference | ||
Causal inference, variational methods, graphical models, Bayesian inference | ||
Extreme value analysis, focused on dependence modelling in multivariate, spatial and spatio-temporal settings and environmental applications. | ||
Probability theory, ergodic theory | ||
Flood risk, multi-hazard risk assessments, statistical seismology, stochastic modelling, seismic hazard and rock mechanics | ||
Methods for longitudinal data, multi-state models, joint models, mixed-effects models, spline models, biostatistics, medical statistics | ||
Lévy processes and applications, optimal control and stopping problems, models of fragmentation and growth, branching processes. | ||
Stochastic models in genetics | ||
Statistical machine learning, multivariate and high-dimensional data analysis, statistical classification, pattern recognition and image analysis |
Unlike the taught Statistics MSc programme, the MPhil/PhD has no required curriculum. However, students are expected to agree on a customised programme of study with their supervisor, which may involve specialisation courses (either at UCL or at the London Taught Course Centre) or independent reading. Attendance at research seminars is encouraged, and students who have been upgraded to PhD status are required to present their research in a separate seminar stream once per year. Finally, the UCL Graduate School has its own requirements for training courses.
Some departmental funding is usually available. UCL also offers a number of scholarships and other funding for UK, EU and overseas students undertaking research studies at the University. Further information, including eligibility criteria and application deadlines, can be found at the links below.
For more information on the programme please contact:
Ms Marina Lewis stats.pgr-admissions AT ucl.ac.uk +44 (0)20 7679 1868
Please note that all professional services staff are currently working away from the office and are therefore unable to take phone calls on the number above.
Widget Placeholder http://mediacentral.ucl.ac.uk/Player/9553
Health data research uk.
8.50 (3527)
The HDR UK-Turing Wellcome PhD Programme provides unrivalled opportunities for people from a variety of academic and professional backgrounds who are inspired to become future leaders in health data science.
Its underlying philosophy is that health data science requires a combination of expertise spanning three fundamental areas: statistical, computational and health sciences.
Enhanced and tax-free stipends with increases every year (Y1: £23,955).
Fully-paid tuition fees at the UK 'Home' rate
Research expenses and travel costs
Bespoke training delivered with our industry and academic partners with a cohort of students
A bursary to support the next step of your career post-PhD
All applications will be reviewed on a rolling basis, so don't hesitate to apply!
If you are considering applying to us you must have (or be on track to obtain):
A first class or 2:1 undergraduate degree in statistics, mathematics, computer science, physics or an allied subject* or
Any undergraduate degree subject and outcome but can demonstrate your suitability for this programme through additional qualifications or research experience.
*Allied subjects can include: engineering, machine learning, data science, robotics, systems biology, bioinformatics/biostatistics, epidemiology.
Applicants for previous rounds need not reapply.
https://www.hdruk.ac.uk/study-and-train/study/phd/hdr-uk-turing-wellcome-phd-programme-in-health-data-science/
https://www.hdruk.ac.uk/wp-content/uploads/2020/09/HDR-UK-PhD-Applicant-Privacy-Notice.pdf
Please feel welcome to contact us with any questions or reasonable adjustments at [email protected] or via phone on +44 (0)770 847 8846.
Start your de-biased application
Statistician Dennis Sun is on a mission to help students see how statistics, data science, and probability apply to their everyday lives by infusing the introductory college courses in these subjects with relatable examples; getting data into the hands of students early; and making his new online statistics textbook freely available—and accessible—for everyone.
If you poked your head into the classroom of Stanford statistician Dennis Sun , you might be surprised by what you see. On one day, you might observe students tossing a beach ball-sized inflatable globe back and forth. On another day, you might see students circling their birth dates on a calendar, performing a Coke versus Pepsi taste test, or counting the clicks of a Geiger counter as it detects radiation.
These activities may seem outlandish, but they are tangible examples of ways we can measure uncertainty and variability—two key concepts in the fields of statistics, data science, and probability.
Creating courses that inspire students to dream up unconventional, useful, and (frequently) fun ways to apply these disciplines to their academic interests and daily lives drives the work of Sun, an associate professor (teaching) of statistics in the Stanford School of Humanities and Sciences and a data scientist at Google.
Sun earned his doctorate in statistics at Stanford in 2015 and joined Stanford’s faculty in 2023. Since then, he has been working to demystify these subjects and help students see that these topics have many practical applications.
“I’ve always been interested in applying statistics to topics you don't traditionally think of,” Sun said. “When I came to Stanford as a graduate student in statistics, I took classes in the music department.”
His subsequent research applied audio signal processing methodology to music, such as the problem of separating out the different instruments in a recording. Building on this research, Sun then applied these methods to speech recognition in noisy recordings.
Blending music with statistics may seem like a disparate mashup but statistics can be applied to just about anything, Sun explained. Unfortunately, statistics and data science aren’t being applied as widely as they could be. One possible reason is that people tend to view these topics as tools for mathematicians and statisticians, and as a result they aren’t always taught in a way that is accessible to everyone.
“Starting with formulas and theorems may work well for students who want to be professional statisticians, but that may not be the best way to connect with all the students who will need statistics in their lives,” Sun said.
This is especially true for students who are exploring career paths and have yet to discover how statistics, probability, and data science could be relevant to their academic interests.
Students interested in pursuing majors in economics, engineering, or biology may not know that data science can be used to, for example, predict house prices and online shopping behavior, identify the variables that affect fuel efficiency for different models of cars, and reveal the likely location of an endangered animals’ territory so conservation efforts can focus there.
“Concrete examples that people can connect with help make statistical concepts more accessible,” Sun said. “We live in a world where uncertainty is inevitable. Statistics is fundamentally about quantifying that uncertainty and using that information to help us make decisions.”
Sun will become director of the Program in Data Science this fall. It is perhaps fitting that he took on the challenge of rethinking the way statistics, data science, and probability are being taught at the introductory college level, because his own interest in statistics was profoundly influenced early in his college career.
“In college I took a very inspirational probability class from a professor who I still consider a mentor today—Joe Blitzstein, professor of statistics at Harvard,” Sun said. “I was a math and music major, but that class led me to take more statistics classes. When I graduated, statistics was what I wanted to do.”
Sun is currently reimagining three essential introductory courses related to data science, statistics, and probability that students take as undergraduates— Principles of Data Science (DATASCI 112), Introduction to Statistics for Engineers and Scientists (STATS 110), and Introduction to Probability (STATS 117) .
“Many students are required to take an introductory statistics class for their major, and many of them are not looking forward to that class,” Sun said. “I'm interested in showing them how statistics can be relevant to their lives, their majors, and their careers.”
To achieve this, Sun pairs relatable scenarios with everyday objects to create memorable learning experiences for his students. One example he recently used in his class involves tossing a large inflatable globe around the classroom.
Sun pulled a beach ball-sized inflatable globe out from behind his desk, tossed it up in the air, and caught it, making a satisfying slap .
“To illustrate a certain idea in statistics called a confidence interval, I pose this question to the class: ‘What percentage of Earth is covered by water, and how could we estimate that?’” Sun said. “Eventually, a student will suggest tossing the inflatable globe around the room. Whenever a person catches it, you see if their finger lands on water or land.”
The students throw the inflatable globe around the room from person to person, tallying the number of times their right index finger lands on water. If, for example, that number is 13 out of 20 times, the corresponding estimate is that 65% of Earth is covered by water.
“The students quickly realize there's some uncertainty associated with that number,” Sun said. “Because if we toss the globe around the class another 20 times, the result might be 15 out of 20, or maybe 12 out of 20. The experience really illustrates the idea of variability and uncertainty, which are central to statistics.”
In addition to his efforts to improve the way that introductory statistics, data science, and probability are being taught, Sun is using two other approaches to make these topics more accessible. The first is getting data into the hands of students early.
Traditionally, students must take several courses in math and probability before they get the opportunity to work with data.
“Working with actual data is what gives students a sense of what data science is all about,” Sun said. “So I created a first-year data science class that students can take their second quarter at Stanford, even if they haven’t taken math courses yet.”
Sun hopes that giving students the option to work with data during their first year of college will be a turning point for them as they weigh different academic paths.
“I’m also working to serve the broader community as well,” Sun said. “How can we, as a society, develop more statistical literacy and help reach more people?”
Sun and two Stanford colleagues in statistics, lecturer Gene Kim , and doctoral scholar Anav Sood , just published a free textbook, The Art of Chance: A Beginner's Guide to Probability , that is available online for anyone who wants to learn more about the topic in a reader-friendly and approachable way.
People are increasingly seeing the value of statistics and data science, Sun explained. But there is still much that can be done to help students get a solid grasp of the fundamentals of these subjects and—hopefully—inspire them to keep studying and learning about these topics in the future.
“When I started as a doctoral student at Stanford, if I told someone I was a statistician, I’d get comments like, ‘statistics, oh I hated that course,’” Sun said. “I think that’s changing. More often you hear, ‘I love my stats course.’”
© Stanford University, Stanford, California 94305
For Medical Students
You can also search for this editor in PubMed Google Scholar
203 Accesses
This is a preview of subscription content, log in via an institution to check access.
Tax calculation will be finalised at checkout
Licence this eBook for your library
Institutional subscriptions
This book introduces basic concepts, principle, and methods of medical statistics systematically and practically, especially in the statistical design of the experiment in terms of the specific problems, adequate use of statistical methods based on actual data and the reasonable explanation for statistical results.
This textbook combines statistical methods with the common application of SPSS software, which is flexible, convenient, and user-friendly; thus, students can focus on the deep understanding of statistics.
The authors emphasize the application and generalization of statistical methods, and combine these methods with the modern statistical theory, such as sequential contingency table and multivariate statistical modelling, etc.
This book is a useful textbook for graduate and undergraduate students in medical schools, including MBBS (Bachelor of Medicine and Bachelor of Surgery) student.
Front matter, introduction to medical statistics.
Fuzhong Xue
Editor Xiuhua Guo is a doctor and professor of Epidemiology and Health Statistics, Capital Medical University, Beijing, China. The main research areas focus on the hierarchical data model or data mining model to handle big data of high dimensional environmental and genetic factors in major infectious diseases, cardiovascular diseases and metabolic disorders, thus to provide scientific proof for the causes of diseases and intervention strategies.
Book Title : Textbook of Medical Statistics
Book Subtitle : For Medical Students
Editors : Xiuhua Guo, Fuzhong Xue
DOI : https://doi.org/10.1007/978-981-99-7390-3
Publisher : Springer Singapore
eBook Packages : Medicine , Medicine (R0)
Copyright Information : Zhengzhou University Press 2024
Softcover ISBN : 978-981-99-7389-7 Published: 20 June 2024
eBook ISBN : 978-981-99-7390-3 Published: 19 June 2024
Edition Number : 1
Number of Pages : XII, 220
Number of Illustrations : 62 b/w illustrations, 24 illustrations in colour
Topics : Epidemiology , Applied Statistics , Biostatistics
Policies and ethics
Attending a private U.K. high school or a university with higher status is tied to better cognitive function, heart health and BMI decades after graduation, according to a new study published Tuesday, and researchers believe more disposable income and physical activity advantages may play a role.
A woman on graduation day.
Around 7% of the study’s participants (all of whom were in the U.K.) attended a private high school, less than 4% attended a grammar school—what the researchers consider “selective without fees”—and 89% of participants went to a state funded school, while 7% attended a higher status university, which are highly regarded Russell Group schools like the University of Oxford and University of Cambridge.
The researchers found those who attended a private high school had better cardiometabolic and cognitive outcomes than those who went to state funded schools, and limited evidence suggests the private school group also had lower BMIs and better blood pressures, according to a paper published in the Journal of Epidemiology & Community Health.
There were no major health differences found between the private school group and the grammar school group except for BMI, where private school attendance was associated with a lower BMI.
Higher-status university attendance was associated with lower BMI and better cognitive performance compared to participants who attended “normal-status” universities; having no degree was associated with the worst health outcomes, except for better grip strength and balance.
The researchers believe a couple reasons may explain the study’s results: Students who attend private high schools typically have greater physical activity than their peers, and participants who attended higher-status schools had more disposable income, so they could focus on their health more.
The study included over 8,500 participants between the ages of 46 and 48, who were a part of the 1970 British Cohort Study followed by researchers since they were born in 1970, and were selected and interviewed about their mid-life health between 2016 and 2018.
A previous study done on the British cohort found those who attended private high schools and high-status universities had lower BMI and better self-reported health scores than their counterparts.
Similar results are visible in the United States: Attending U.S. colleges with selective admission rates was associated with slightly higher cognitive performance later in life, a Research on Aging study found. Adolescents who attend U.S. schools with advantages like smaller student-to-teacher ratios and teachers with better salaries have better cognitive skills between the ages of 65 and 72 than those who attend schools with less or no advantages, according to a 2020 study . Higher economic status, social position and more access to “highly-resourced” elementary and middle schools are all reasons the researchers found for these health outcomes. Researchers also discovered higher education helps people find higher paying jobs with less safety hazards, so this may factor into the better health outcomes.
Receiving any type of education after high school has also been linked to better health outcomes worldwide. The higher a person's level of education, the lower their risk of premature death, according to a January global study published in the Lancet. A person's risk of death dropped by an average of 2% with every additional year of education they attained, the study found.
Education level has also been linked to specific health conditions. People whose highest level of education was middle or elementary school had a 52% higher risk of dying from coronary heart disease than those who attended graduate school, according to a 2019 study . Diabetes risk may also decrease with more education: 13.1% of adults in the U.S. who have diabetes have less than a high school education, compared to 9.1% who graduated high school and 6.9% with more than a high school education. Black and white people with 12 or less years of education have between a 60% and 180% higher cancer mortality rate versus those with 16 or more years of education, a study by the American Cancer Society found.
One Community. Many Voices. Create a free account to share your thoughts.
Our community is about connecting people through open and thoughtful conversations. We want our readers to share their views and exchange ideas and facts in a safe space.
In order to do so, please follow the posting rules in our site's Terms of Service. We've summarized some of those key rules below. Simply put, keep it civil.
Your post will be rejected if we notice that it seems to contain:
User accounts will be blocked if we notice or believe that users are engaged in:
So, how can you be a power user?
Thanks for reading our community guidelines. Please read the full list of posting rules found in our site's Terms of Service.
Our websites may use cookies to personalize and enhance your experience. By continuing without changing your cookie settings, you agree to this collection. For more information, please see our University Websites Privacy Notice .
June 21, 2024 | Ashley O'Connell and Nicole Dobrzanski, UConn School of Nursing
Associate Dean Dr. Annette Jakubisin-Konicki, PhD, ANP-BC, FNP-BC, FAANP, FAAN receives award to provide a low-interest option for students.
UConn School of Nursing. (Peter Morenus/UConn Photo)
The School of Nursing has been awarded $763,308 through the Health Resources & Services Administration’s (HRSA) Nurse Faculty Loan Program (NFLP). Launched in 2004, this program seeks to increase the number of qualified nursing faculty through their low interest loans to help prepare and train qualified nurse educators to fill faculty vacancies and increase the number of nurses entering the workforce.
“A robust, geographically dispersed nurse faculty workforce is essential to producing the nursing workforce needed to meet US health care needs,” the NFLP states. The School of Nursing applies for NFLP funding each year to support nurses pursuing doctoral education who are interested in becoming nursing faculty.
NFLP- eligible students enrolled in either the DNP or PhD programs at UConn may apply for funding in Fall 2024. The NFLP funds cover tuition and other qualified cost for up to five years, with a maximum of $40,000 per year. Students awarded the NFLP funding may cancel 85% of their loan in return for serving four consecutive years as faculty in any accredited school of nursing or precepting advanced practice nursing students within an academic-practice partnership framework for four years.
The Project Director (PD) for this award is Dr. Annette Jakubišin-Konicki (PhD, ANP-BC, FNP-BC, FAANP, FAAN). Dr. Jakubišin-Konicki is the Associate Dean for Graduate Studies. The award administration is through the cooperative efforts of the UConn School of Nursing, Financial Aid and Bursar’s Office. The applications, available in fall 2024 will be on a first-come, first-served basis. Priority funding is given to those with prior NFLP funding, pursuing doctoral nursing education and meeting the eligibility requirements.
“The Nurse Faculty Loan Program (NFLP) is essential for expanding nursing training capacity. It supports nursing doctoral education, increasing the pool of qualified nursing faculty. By offering low-interest loans, it encourages doctorally prepared nurses to become effective faculty scholars and reduces the associated financial barriers through loan cancellation.”- Dr. Annette Jakubišin-Konicki
In receiving this award, UConn’s School of Nursing hopes to further expand the accessibility and the capabilities of its students. The opening of the application cycle for the upcoming academic year will occur in August.
For any further information, please contact Dr. Jakubišin-Konicki at [email protected].
June 21, 2024
Read the article
June 20, 2024
COMMENTS
About the course. As a DPhil student in Clinical Epidemiology and Medical Statistics, you will spend up to four years in one of the Botnar Research Centre's many research groups, working on a research project supervised by one of the principal investigators and your supervisory team. You will take part in the extensive training programme ...
The PhD in Biostatistics provides training in the theory of probability and statistics in biostatistical methodology. The program is unique in its emphasis on the foundations of statistical reasoning and data science. ... Tuition, fees, and medical benefits are provided, including health insurance premiums for PhD student's children and ...
FUNDING. All students admitted to the PhD in biostatistics program, including international students, are guaranteed full funding, which includes a stipend as well as tuition and health insurance for four years, provided they make satisfactory progress. In practice, many students require a fifth year to complete the doctoral program, and ...
The Medical Statistics program uses real-world examples from medical literature and the popular press to introduce statistical concepts and techniques commonly utilized in medical research. ... After receiving an MS in statistics and a PhD in epidemiology from Stanford University, she studied science writing at the University of California ...
A PhD in Medical Statistics will require you to provide expert statistical inputs to issues in medical health research. You'll be concerned with either applying existing or developing new statistical methods in areas of medicine like public health, clinical trials or epidemiology. Statistics has a major role to play across medicine and public ...
Fully funded (and no tuition) PhD program in psychiatric, translational research and basic Neuroscience with the option for a residency track for medical doctors. Max Planck Society. We welcome applications starting on August 15, 2024 for a start in fall 2025 (deadline October 31, 2024). The International Max Planck Research School for ...
Department of Biostatistics. Advancing health science research, education, and practice by turning data into knowledge and addressing the greatest public health issues of the 21st century. The Department of Biostatistics at the Harvard Chan School offers an unparalleled environment to pursue research and education in statistical science while ...
The PhD program in biostatistics prepares individuals to develop or adapt statistical methods for solving problems in the health field. Students enjoy extensive library and computer facilities, as well as myriad opportunities for involvement in numerous research activities in the biomedical sciences and clinical research, which often lead to ...
The Graduate Group in Epidemiology and Biostatistics (GGEB) is responsible for developing and administering the PhD degree programs in epidemiology and biostatistics as well as the MS program in biostatistics. The PhD programs train individuals to be rigorous and independent academic investigators, able to develop, apply and extend biostatistical and epidemiological methodology to address ...
Description The doctoral program in Biostatistics trains future leaders, highly qualified as independent investigators and teachers, and who are well-trained practitioners of biostatistics. The program includes coursework in biostatistics, statistics, and one or more public health or biomedical fields. In addition, successful candidates are required to pass PhD applied and theory exams and ...
The 16-month program blends strong statistical and computational training to solve emerging problems in public health and the biomedical sciences. This training will enable students to manage and analyze massive, noisy data sets and learn how to interpret their findings. The program will provide training in three principal pillars of health ...
A PhD degree in Biostatistics requires a program of courses selected from biostatistics, statistics, and at least one other subject area (such as environmental health, epidemiology, or genomics), an oral qualifying examination, and a dissertation. Courses cover traditional topics as well as recent advances in biostatistics and statistics.
Statistics Program. The Department of Biostatistics and Computational Biology at the University of Rochester conducts teaching and research in statistical theory and methodology oriented toward the health sciences. Our unique graduate program is located within a School of Medicine environment and provides many opportunities for stimulating ...
Contact. Graduate School of Biomedical Sciences Tufts University Suite 501 136 Harrison Avenue Boston, MA 02111. 617-636-6767 [email protected]
KU's Ph.D. in Biostatistics program is nationally regarded for producing highly skilled biostatisticians prepared to collaborate or lead in a variety of fields. The Ph.D. in Biostatistics at KU Medical Center is a 63-credit-hour program, recognized for the quality, ability and training of its graduating students.
The Doctor of Philosophy (PhD) program in Biostatistics & Data Science prepares each graduate to lead cutting-edge research and act as a consummate resource in the design, analysis, and interpretation of a wide array of studies. Graduates will possess the technical and collaborative skills necessary to work with clinicians, epidemiologists, private companies, and population health organizations.
Admissions Data (2020-2024) Average Applications per Year: 695: Average Interviews per Year: 84: Average Number of Funded Matriculants per Year: 14: Average MCAT Score
Statistics PhD students who are U.S. citizens or permanent residents may apply to join our T32 training program. The goal of this training grant is to prepare qualified predoctoral and/or postdoctoral trainees for careers that have a significant impact on the health-related research needs of the nation.
MD-PhD Matriculants to U.S. Medical Schools by Race/Ethnicity and State of Legal Residence, 2023-2024: PDF: Excel: B-10: MCAT Scores and GPAs for MD-PhD Applicants and Matriculants to U.S. Medical Schools, 2019-2020 through 2023-2024: PDF: Excel: B-11.1: Total MD-PhD Enrollment by U.S. Medical School and Gender, 2014-2015 through 2018-2019: PDF ...
Scholarships and funding. Study PhD or MSc by Research in Population Health Sciences at the University of Edinburgh. Our postgraduate degree programme looks at epidemiology, genetic epidemiology, health promotion, health services research, medical statistics, molecular epidemiology and sociology. Find out more here.
PhD in Biostatistics. The MRC Biostatistics Unit is an internationally recognised research department of the University of Cambridge specialising in statistical modelling with application to medical, biological or public health sciences. Our PhD students are registered with the University of Cambridge. Students belong to one of the University's ...
Introduction. This two-part series will present basic statistical principles for the practicing physician to use in his or her review of the literature and to the physician engaged in clinical research. The purpose of this series is threefold: (1) to provide an overview of common epidemiological and statistical terms and concepts that can be ...
The typical length of the PhD programme is three years for full-time students and five years for part-time students; an MPhil might be achievable in less. The admissions process for the MPhil/PhD in Statistical Science operates on a rolling basis, with no fixed deadline for applications. Candidates should apply at least two months in advance of ...
Summary:The HDR UK-Turing Wellcome PhD Programme provides unrivalled opportunities for people from a variety of academic and professional backgrounds who are inspired to become future leaders in health data science.Its underlying philosophy is that health data science requires a combination of expertise spanning three fundamental areas: statistical, computational and health sciences.Our ...
Statistician Dennis Sun is on a mission to help students see how statistics, data science, and probability apply to their everyday lives by infusing the introductory college courses in these subjects with relatable examples; getting data into the hands of students early; and making his new online statistics textbook freely available—and accessible—for everyone.
Editor Xiuhua Guo is a doctor and professor of Epidemiology and Health Statistics, Capital Medical University, Beijing, China. The main research areas focus on the hierarchical data model or data mining model to handle big data of high dimensional environmental and genetic factors in major infectious diseases, cardiovascular diseases and metabolic disorders, thus to provide scientific proof ...
People whose highest level of education was middle or elementary school had a 52% higher risk of dying from coronary heart disease than those who attended graduate school, according to a 2019 study.
The School of Nursing has been awarded $763,308 through the Health Resources & Services Administration's (HRSA) Nurse Faculty Loan Program (NFLP). Launched in 2004, this program seeks to increase the number of qualified nursing faculty through their low interest loans to help prepare and train qualified nurse educators to fill faculty ...